Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Activation of the hypothalamic-pituitary-adrenal (HPA) axis contributes to the immunosuppression of mice infected with Angiostrongylus cantonensis.

Chen AL, Sun X, Wang W, Liu JF, Zeng X, Qiu JF, Liu XJ, Wang Y.

J Neuroinflammation. 2016 Oct 12;13(1):266.

2.

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.

Massanella M, Gómez-Mora E, Carrillo J, Curriu M, Ouchi D, Puig J, Negredo E, Cabrera C, Clotet B, Blanco J.

J Transl Med. 2015 Jul 17;13:230. doi: 10.1186/s12967-015-0601-2.

3.

Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery.

Pitrak DL, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL.

AIDS Res Hum Retroviruses. 2015 Feb;31(2):208-16. doi: 10.1089/aid.2014.0038. Epub 2014 Nov 11.

4.

Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.

Rosenblum JM, Kirk AD.

Immunol Rev. 2014 Mar;258(1):167-82. doi: 10.1111/imr.12155. Review.

5.

Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.

Kalayjian RC, Spritzler J, Matining RM, Fiscus SA, Gross BH, Francis IR, Pollard RB, Lederman MM, Landay A.

AIDS. 2013 Jun 19;27(10):1563-71. doi: 10.1097/QAD.0b013e32835fabc2.

6.

Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.

Borges M, Barreira-Silva P, Flórido M, Jordan MB, Correia-Neves M, Appelberg R.

J Immunol. 2012 Oct 1;189(7):3600-8. Epub 2012 Aug 24.

7.

HIV RNA suppression and immune restoration: can we do better?

Pinzone MR, Di Rosa M, Cacopardo B, Nunnari G.

Clin Dev Immunol. 2012;2012:515962. doi: 10.1155/2012/515962. Epub 2012 Mar 25. Review.

8.

Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.

Gaardbo JC, Hartling HJ, Gerstoft J, Nielsen SD.

Clin Dev Immunol. 2012;2012:670957. doi: 10.1155/2012/670957. Epub 2012 Mar 14. Review.

9.

Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy.

Palermo B, Bosch RJ, Bennett K, Jacobson JM.

HIV Clin Trials. 2011 Jul-Aug;12(4):222-7. doi: 10.1310/HCT1204-222.

10.

Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.

Rajasuriar R, Gouillou M, Spelman T, Read T, Hoy J, Law M, Cameron PU, Petoumenos K, Lewin SR.

PLoS One. 2011;6(6):e20713. doi: 10.1371/journal.pone.0020713. Epub 2011 Jun 2.

11.

Immunologic basis for revaccination of HIV-infected children receiving HAART.

Rainwater-Lovett K, Moss WJ.

Future Virol. 2011 Jan 1;6(1):59-71.

12.

Evidence that androgens modulate human thymic T cell output.

Olsen NJ, Kovacs WJ.

J Investig Med. 2011 Jan;59(1):32-5.

13.

Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression.

Rafie C, Campa A, Smith S, Huffman F, Newman F, Baum MK.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):815-22. doi: 10.1089/AID.2010.0086. Epub 2011 Jan 15.

14.

Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174.

Smith K, Zheng L, Bosch R, Margolis DM, Tenorio A, Napolitano L, Saag M, Connick E, Gross B, Francis I, Valdez H, Muurahainen N, Stocker V, Pollard R.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):425-32. doi: 10.1089/aid.2009.0052. Erratum in: AIDS Res Hum Retroviruses. 2010 Jul;26(7):839. Margolis, David M [added].

15.

Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy.

Nies-Kraske E, Schacker TW, Condoluci D, Orenstein J, Brenchley J, Fox C, Daucher M, Dewar R, Urban E, Hill B, Guenaga J, Hoover S, Maldarelli F, Hallahan CW, Horn J, Kottilil S, Chun TW, Folino M, Palmer S, Wiegand A, O'Shea MA, Metcalf JA, Douek DC, Coffin J, Haase A, Fauci AS, Dybul M.

J Infect Dis. 2009 Jun 1;199(11):1648-56. doi: 10.1086/598980.

16.

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.

Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6. doi: 10.1097/QAI.0b013e31817bebb3.

17.

Growth hormone enhances thymic function in HIV-1-infected adults.

Napolitano LA, Schmidt D, Gotway MB, Ameli N, Filbert EL, Ng MM, Clor JL, Epling L, Sinclair E, Baum PD, Li K, Killian ML, Bacchetti P, McCune JM.

J Clin Invest. 2008 Mar;118(3):1085-98. doi: 10.1172/JCI32830.

18.

T cell immune reconstitution following lymphodepletion.

Williams KM, Hakim FT, Gress RE.

Semin Immunol. 2007 Oct;19(5):318-30. Epub 2007 Nov 19. Review.

19.

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.

Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, Dandekar S.

J Virol. 2006 Aug;80(16):8236-47.

20.

Age-dependent incidence, time course, and consequences of thymic renewal in adults.

Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, Odom J, Vance BA, Christensen BL, Mackall CL, Gress RE.

J Clin Invest. 2005 Apr;115(4):930-9. Epub 2005 Mar 17.

Supplemental Content

Support Center